Segmented chelating polymers as imaging and therapeutic agents

A composition suitable for use in diagnostic imaging or as a cell killing agent comprising a chelating residue linked via an amide linkage to a poly(alkylene oxide) moiety, said composition having a molecular weight of at least 4,500; wherein: Z is a chelating residue; Q is a divalent poly(alkylene...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JULIA SHIEH TAN, DENNIS KIYOSHI FUJII, ROBERT ALLAN SNOW, JOHN LUKE TONER, DENNIS EARL BUTTERFIELD, DAVID LEE LADD
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JULIA SHIEH TAN
DENNIS KIYOSHI FUJII
ROBERT ALLAN SNOW
JOHN LUKE TONER
DENNIS EARL BUTTERFIELD
DAVID LEE LADD
description A composition suitable for use in diagnostic imaging or as a cell killing agent comprising a chelating residue linked via an amide linkage to a poly(alkylene oxide) moiety, said composition having a molecular weight of at least 4,500; wherein: Z is a chelating residue; Q is a divalent poly(alkylene oxidylene) moiety having a carbon terminus at R and at L; L represents an amide linkage; E(b) is one or more counterions each having a charge of b; b is an integer from 1, 2 and 3; n is an integer selected from the group 1, 2, 3 and 4; w is zero or an integer from 1 to 5; M(+a) is a cation, having a charge of +a; a is an integer from 1 to 4; r is 0 or an integer from 1 to 3, provided that when r is 2-3, each M(+a) can be the same or different cation; d is the total charge on the chelating residue and is an integer from 0 to 10; d+ SIGMA (bxw)+ SIGMA (axr)=O; and R is a capping moiety chosen from the group consisting of hydrogen, hydroxyl, C1-C4 alkyl, aryl containing 6 to 24 carbon atoms, C2-C5 alkanoyloxyl and C1-C4 alkoxy, or R is an immunoreactive group or cytotoxic drug linked to Q by a chemical bond or a linking group.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2080595A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2080595A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2080595A3</originalsourceid><addsrcrecordid>eNrjZLALTk3PTc0rSU1RSM5IzUksycxLVyjIz6nMTS0qVkgsVsjMTUwHiSXmpSiUZKQWJRaklpZkJiskpgN1FfMwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknjHUCMDCwNTS1NHY8IqAL1IMA4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Segmented chelating polymers as imaging and therapeutic agents</title><source>esp@cenet</source><creator>JULIA SHIEH TAN ; DENNIS KIYOSHI FUJII ; ROBERT ALLAN SNOW ; JOHN LUKE TONER ; DENNIS EARL BUTTERFIELD ; DAVID LEE LADD</creator><creatorcontrib>JULIA SHIEH TAN ; DENNIS KIYOSHI FUJII ; ROBERT ALLAN SNOW ; JOHN LUKE TONER ; DENNIS EARL BUTTERFIELD ; DAVID LEE LADD</creatorcontrib><description>A composition suitable for use in diagnostic imaging or as a cell killing agent comprising a chelating residue linked via an amide linkage to a poly(alkylene oxide) moiety, said composition having a molecular weight of at least 4,500; wherein: Z is a chelating residue; Q is a divalent poly(alkylene oxidylene) moiety having a carbon terminus at R and at L; L represents an amide linkage; E(b) is one or more counterions each having a charge of b; b is an integer from 1, 2 and 3; n is an integer selected from the group 1, 2, 3 and 4; w is zero or an integer from 1 to 5; M(+a) is a cation, having a charge of +a; a is an integer from 1 to 4; r is 0 or an integer from 1 to 3, provided that when r is 2-3, each M(+a) can be the same or different cation; d is the total charge on the chelating residue and is an integer from 0 to 10; d+ SIGMA (bxw)+ SIGMA (axr)=O; and R is a capping moiety chosen from the group consisting of hydrogen, hydroxyl, C1-C4 alkyl, aryl containing 6 to 24 carbon atoms, C2-C5 alkanoyloxyl and C1-C4 alkoxy, or R is an immunoreactive group or cytotoxic drug linked to Q by a chemical bond or a linking group.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; COMPOSITIONS BASED THEREON ; HUMAN NECESSITIES ; HYGIENE ; MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC MACROMOLECULAR COMPOUNDS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951023&amp;DB=EPODOC&amp;CC=AU&amp;NR=2080595A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951023&amp;DB=EPODOC&amp;CC=AU&amp;NR=2080595A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JULIA SHIEH TAN</creatorcontrib><creatorcontrib>DENNIS KIYOSHI FUJII</creatorcontrib><creatorcontrib>ROBERT ALLAN SNOW</creatorcontrib><creatorcontrib>JOHN LUKE TONER</creatorcontrib><creatorcontrib>DENNIS EARL BUTTERFIELD</creatorcontrib><creatorcontrib>DAVID LEE LADD</creatorcontrib><title>Segmented chelating polymers as imaging and therapeutic agents</title><description>A composition suitable for use in diagnostic imaging or as a cell killing agent comprising a chelating residue linked via an amide linkage to a poly(alkylene oxide) moiety, said composition having a molecular weight of at least 4,500; wherein: Z is a chelating residue; Q is a divalent poly(alkylene oxidylene) moiety having a carbon terminus at R and at L; L represents an amide linkage; E(b) is one or more counterions each having a charge of b; b is an integer from 1, 2 and 3; n is an integer selected from the group 1, 2, 3 and 4; w is zero or an integer from 1 to 5; M(+a) is a cation, having a charge of +a; a is an integer from 1 to 4; r is 0 or an integer from 1 to 3, provided that when r is 2-3, each M(+a) can be the same or different cation; d is the total charge on the chelating residue and is an integer from 0 to 10; d+ SIGMA (bxw)+ SIGMA (axr)=O; and R is a capping moiety chosen from the group consisting of hydrogen, hydroxyl, C1-C4 alkyl, aryl containing 6 to 24 carbon atoms, C2-C5 alkanoyloxyl and C1-C4 alkoxy, or R is an immunoreactive group or cytotoxic drug linked to Q by a chemical bond or a linking group.</description><subject>CHEMISTRY</subject><subject>COMPOSITIONS BASED THEREON</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC MACROMOLECULAR COMPOUNDS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLALTk3PTc0rSU1RSM5IzUksycxLVyjIz6nMTS0qVkgsVsjMTUwHiSXmpSiUZKQWJRaklpZkJiskpgN1FfMwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknjHUCMDCwNTS1NHY8IqAL1IMA4</recordid><startdate>19951023</startdate><enddate>19951023</enddate><creator>JULIA SHIEH TAN</creator><creator>DENNIS KIYOSHI FUJII</creator><creator>ROBERT ALLAN SNOW</creator><creator>JOHN LUKE TONER</creator><creator>DENNIS EARL BUTTERFIELD</creator><creator>DAVID LEE LADD</creator><scope>EVB</scope></search><sort><creationdate>19951023</creationdate><title>Segmented chelating polymers as imaging and therapeutic agents</title><author>JULIA SHIEH TAN ; DENNIS KIYOSHI FUJII ; ROBERT ALLAN SNOW ; JOHN LUKE TONER ; DENNIS EARL BUTTERFIELD ; DAVID LEE LADD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2080595A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>COMPOSITIONS BASED THEREON</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC MACROMOLECULAR COMPOUNDS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>THEIR PREPARATION OR CHEMICAL WORKING-UP</topic><toplevel>online_resources</toplevel><creatorcontrib>JULIA SHIEH TAN</creatorcontrib><creatorcontrib>DENNIS KIYOSHI FUJII</creatorcontrib><creatorcontrib>ROBERT ALLAN SNOW</creatorcontrib><creatorcontrib>JOHN LUKE TONER</creatorcontrib><creatorcontrib>DENNIS EARL BUTTERFIELD</creatorcontrib><creatorcontrib>DAVID LEE LADD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JULIA SHIEH TAN</au><au>DENNIS KIYOSHI FUJII</au><au>ROBERT ALLAN SNOW</au><au>JOHN LUKE TONER</au><au>DENNIS EARL BUTTERFIELD</au><au>DAVID LEE LADD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Segmented chelating polymers as imaging and therapeutic agents</title><date>1995-10-23</date><risdate>1995</risdate><abstract>A composition suitable for use in diagnostic imaging or as a cell killing agent comprising a chelating residue linked via an amide linkage to a poly(alkylene oxide) moiety, said composition having a molecular weight of at least 4,500; wherein: Z is a chelating residue; Q is a divalent poly(alkylene oxidylene) moiety having a carbon terminus at R and at L; L represents an amide linkage; E(b) is one or more counterions each having a charge of b; b is an integer from 1, 2 and 3; n is an integer selected from the group 1, 2, 3 and 4; w is zero or an integer from 1 to 5; M(+a) is a cation, having a charge of +a; a is an integer from 1 to 4; r is 0 or an integer from 1 to 3, provided that when r is 2-3, each M(+a) can be the same or different cation; d is the total charge on the chelating residue and is an integer from 0 to 10; d+ SIGMA (bxw)+ SIGMA (axr)=O; and R is a capping moiety chosen from the group consisting of hydrogen, hydroxyl, C1-C4 alkyl, aryl containing 6 to 24 carbon atoms, C2-C5 alkanoyloxyl and C1-C4 alkoxy, or R is an immunoreactive group or cytotoxic drug linked to Q by a chemical bond or a linking group.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2080595A
source esp@cenet
subjects CHEMISTRY
COMPOSITIONS BASED THEREON
HUMAN NECESSITIES
HYGIENE
MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC MACROMOLECULAR COMPOUNDS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
THEIR PREPARATION OR CHEMICAL WORKING-UP
title Segmented chelating polymers as imaging and therapeutic agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A19%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JULIA%20SHIEH%20TAN&rft.date=1995-10-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2080595A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true